% | $
Quotes you view appear here for quick access.

iShares Nasdaq Biotechnology Message Board

  • scanit2008 scanit2008 Mar 8, 2013 11:24 AM Flag

    Amarantus Bioscience - AMBS

    Currently trading under a dime.

    Considering the potential impact of the "Human Brain Mapping Project", the investment to date of approximately $35,000,000 in developing the patented MANF technology, and the value attached to Amarantus Diagnostics, and the fact that the GDNF technology sold for $265,000,000 I would attach a current value to Amarantus Bioscience in the $100,000,000 range or about .45/share.

    A joint venture or "big pharma" partnership announcement and the resulting short squeeze could take it much higher ($1.00?) but it would probably settle in the .45-.50 range.

284.36+4.08(+1.46%)1:10 PMEDT